The rare hematologic malignancy known as chronic myelomonocytic leukemia was the subject of a recent study that compared outcomes from patients treated at academic centers versus nonacademic centers.

On the basis of the data suggesting that adolescents and young adult patients with acute lymphoblastic leukemia (ALL) have improved outcomes when treated on pediatric protocols, we assessed the ...

"Acute lymphoblastic leukemia with myeloid mutations is a high-risk disease associated with clonal hematopoiesis," is published in Blood Cancer Discovery. Disease pathology differs between adult ...

The following is a summary of “Critically ill adult patients with acute leukemia: a systematic review and meta-analysis,” published in the January 2025 issue of Critical Care by Chean et al. Researche ...

in adults with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) (a fast-growing cancer of immature B-cells in the blood and bone marrow). Chimeric antigen receptor (CAR ...

Aucatzyl Approved for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Danziten (nilotinib) Kinase inhibitor For the treatment of adults with newly diagnosed Philadelphia chromosome ...